Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.3K Buy
414
+269
+186% +$6.34K ﹤0.01% 1666
2026
Q1
$3.28K Sell
145
-258
-64% -$6.1K ﹤0.01% 1861
2025
Q4
$10.9K Sell
403
-44
-10% -$1.3K ﹤0.01% 1386
2025
Q3
$14.3K Buy
+447
New +$13.6K ﹤0.01% 1039

Other funds holding ENOV

Salomon & Ludwin's ENOV Position: Q2 2026 in Review

Salomon & Ludwin increased its Enovis (ENOV) stake by 186% in Q2 2026, buying an estimated $6.34K and bringing the position to 414 shares worth $8.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1666.

Salomon & Ludwin first reported a position in ENOV in Q3 2025 and has held it in 4 quarters since. The position peaked at $14.3K in Q3 2025. 253 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Salomon & Ludwin held 414 shares of Enovis worth $8.3K as of Q2 2026.
  • Salomon & Ludwin bought 269 Enovis shares in Q2 2026, an estimated $6.34K.
  • Enovis made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1666 holding.
  • Salomon & Ludwin first reported a position in Enovis in Q3 2025 and has held it in 4 quarters since.
  • Salomon & Ludwin's Enovis position peaked at $14.3K in Q3 2025.
  • 253 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.